- Professor, Oncology, Cancer Biology Research Center, Tel Aviv University
- Head, Oncology Division, Tel Aviv Sourasky Medical Center, Parasol Center for Women’s Cancer Research
Dr. Ido Wolf is a Professor of Oncology at the Gray Faculty of Medical and Health Sciences, Tel Aviv University, and Head of the Oncology Division at Tel Aviv Sourasky Medical Center (Ichilov), where he also leads the Parasol Center for Women’s Cancer Research. He earned his MD from Ben-Gurion University of the Negev and completed advanced training at the Weizmann Institute of Science and the Cancer Research Center at UCLA.
Dr. Wolf’s research focuses on the endocrine aspects of cancer, organized around three main areas: the tumor suppressor role of the hormone Klotho in breast, pancreatic, and ovarian cancers; estrogen receptor (ESR1) mutations that confer resistance to hormonal therapies in metastatic breast cancer; and the mechanisms by which mutations direct cancer cell homing to specific organs via metabolic pathways. For the Colton Consortium, his group is studying immunotherapy-related adverse effects as models for fragile immune tolerance in humans.
He has authored over 600 peer-reviewed publications and has served on national advisory boards for drug registration, clinical trials, and oncology policy at Israel’s Ministry of Health. He was listed among Israel’s best physicians by Forbes in 2019.
